|
|
|
Insider
Information: |
Bobo Donald E Jr |
Relationship: |
CVP,Strategy/Corp Deve... |
City: |
Irvine |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
1 |
|
Direct
Shares |
46,936 |
|
Indirect Shares
|
173,767 |
|
|
Direct
Value |
$1,408,085 |
|
|
Indirect Value
|
$5,213,027 |
|
|
Total
Shares |
220,703 |
|
|
Total
Value |
$6,621,112 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
5
|
Stock
price went up :
|
0
|
4
|
Stock
price went down : |
0
|
1
|
|
|
|
Gain/Loss Ratio : |
0.0
|
4.0
|
Percentage
Gain/Loss : |
0.0%
|
105.4%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Edwards Lifesciences Corp |
EW |
CVP,Strategy/Corp Deve... |
2024-05-11 |
46,936 |
2024-05-11 |
173,767 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
324 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 7 of 13
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
EW |
Edwards Lifesciences Corp |
CVP, Heart Valve Therapy |
|
2017-06-29 |
4 |
OE |
$44.62 |
$249,844 |
D/D |
5,600 |
90,783 |
0 |
- |
|
EW |
Edwards Lifesciences Corp |
CVP, Heart Valve Therapy |
|
2017-06-29 |
4 |
AS |
$116.89 |
$656,035 |
D/D |
(5,600) |
85,183 |
0 |
- |
|
EW |
Edwards Lifesciences Corp |
CVP,Strategy/Corp Development |
|
2023-05-05 |
4 |
S |
$88.63 |
$499,402 |
D/D |
(5,635) |
56,225 |
0 |
% |
|
EW |
Edwards Lifesciences Corp |
CVP, Heart Valve Therapy |
|
2017-05-10 |
4 |
D |
$110.58 |
$626,104 |
D/D |
(5,662) |
82,283 |
0 |
- |
|
EW |
Edwards Lifesciences Corp |
CVP,Strategy/Corp Development |
|
2023-05-03 |
4 |
GD |
$0.00 |
$0 |
I/I |
5,715 |
111,605 |
0 |
- |
|
EW |
Edwards Lifesciences Corp |
CVP, Heart Valve Therapy |
|
2016-11-29 |
4 |
GD |
$0.00 |
$0 |
I/I |
5,754 |
9,604 |
0 |
- |
|
EW |
Edwards Lifesciences Corp |
CVP,Strategy/Corp Development |
|
2024-05-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,855 |
45,144 |
0 |
- |
|
EW |
Edwards Lifesciences Corp |
CVP,Strategy/Corp Development |
|
2018-05-23 |
4 |
S |
$137.51 |
$825,083 |
D/D |
(6,000) |
20,012 |
0 |
- |
|
EW |
Edwards Lifesciences Corp |
CVP,Strategy/Corp Development |
|
2023-11-13 |
4 |
OE |
$36.75 |
$220,500 |
D/D |
6,000 |
45,503 |
0 |
- |
|
EW |
Edwards Lifesciences Corp |
CVP,Strategy/Corp Development |
|
2023-11-13 |
4 |
AS |
$64.72 |
$391,780 |
D/D |
(6,000) |
39,503 |
0 |
% |
|
EW |
Edwards Lifesciences Corp |
CVP,Strategy/Corp Development |
|
2020-05-11 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,343 |
28,790 |
0 |
- |
|
EW |
Edwards Lifesciences Corp |
CVP,Strategy/Corp Development |
|
2023-05-11 |
4 |
A |
$0.00 |
$0 |
D/D |
6,425 |
39,503 |
0 |
- |
|
EW |
Edwards Lifesciences Corp |
CVP,Strategy/Corp Development |
|
2024-05-07 |
4 |
A |
$0.00 |
$0 |
D/D |
6,700 |
48,369 |
0 |
- |
|
EW |
Edwards Lifesciences Corp |
CVP,Strategy/Corp Development |
|
2022-05-09 |
4 |
AS |
$98.71 |
$663,825 |
D/D |
(6,725) |
64,304 |
0 |
% |
|
EW |
Edwards Lifesciences Corp |
CVP,Strategy/Corp Development |
|
2022-05-09 |
4 |
OE |
$35.20 |
$236,698 |
D/D |
6,725 |
71,029 |
0 |
- |
|
EW |
Edwards Lifesciences Corp |
CVP,Strategy/Corp Development |
|
2022-06-13 |
4 |
AS |
$89.93 |
$605,410 |
D/D |
(6,725) |
62,561 |
0 |
% |
|
EW |
Edwards Lifesciences Corp |
CVP,Strategy/Corp Development |
|
2022-06-13 |
4 |
OE |
$35.20 |
$236,698 |
D/D |
6,725 |
69,286 |
0 |
- |
|
EW |
Edwards Lifesciences Corp |
CVP,Strategy/Corp Development |
|
2022-07-08 |
4 |
OE |
$35.20 |
$236,698 |
D/D |
6,725 |
69,286 |
0 |
- |
|
EW |
Edwards Lifesciences Corp |
CVP,Strategy/Corp Development |
|
2022-07-08 |
4 |
AS |
$97.60 |
$656,360 |
D/D |
(6,725) |
62,561 |
0 |
% |
|
EW |
Edwards Lifesciences Corp |
CVP,Strategy/Corp Development |
|
2022-08-09 |
4 |
OE |
$35.20 |
$236,698 |
D/D |
6,725 |
69,286 |
0 |
- |
|
EW |
Edwards Lifesciences Corp |
CVP,Strategy/Corp Development |
|
2022-08-09 |
4 |
AS |
$105.01 |
$706,192 |
D/D |
(6,725) |
62,561 |
0 |
% |
|
EW |
Edwards Lifesciences Corp |
CVP,Strategy/Corp Development |
|
2022-09-08 |
4 |
AS |
$90.94 |
$611,572 |
D/D |
(6,725) |
62,561 |
0 |
- |
|
EW |
Edwards Lifesciences Corp |
CVP,Strategy/Corp Development |
|
2022-09-08 |
4 |
OE |
$35.20 |
$236,698 |
D/D |
6,725 |
69,286 |
0 |
- |
|
EW |
Edwards Lifesciences Corp |
CVP,Strategy/Corp Development |
|
2022-10-10 |
4 |
AS |
$85.00 |
$571,625 |
D/D |
(6,725) |
62,561 |
0 |
% |
|
EW |
Edwards Lifesciences Corp |
CVP,Strategy/Corp Development |
|
2022-10-10 |
4 |
OE |
$35.20 |
$236,698 |
D/D |
6,725 |
69,286 |
0 |
- |
|
324 Records found
|
|
Page 7 of 13 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|